Effect of Aloe Vera Gel Extract on C-Reactive Protein Variations Induced by Methotrexate in Albino Rats
DOI:
https://doi.org/10.46966/msjar.v5i3.218Keywords:
Methotrexate (MTX), C-Reactive Protein (CRP), Aloe Vera Gel ExtractAbstract
Background: The present research attempts to investigate the efficiency of the gel form of aloe Vera against side effects that are induced by the effecting of the drug Methotrexate in adult Albino rats with highly sensitive C-reactive protein and provide protection and treatment from this deficiency, if drugs are taken alone or in combination in cases where require it, Group 1: control, Group2: Methotrexate 1mg/kg Group3: give gel of Aloe Vera 250 mg/ kg, Group4: give gel of Aloe Vera 500 mg/ kg,, Group5: MTX 1 mg /kg with 250 mg/kg, Group6: MTX 1 mg/ kg with 500 mg/kg. Samples of blood were taken from every animal after the finish of the three-week study. The results indicated a significant reduction in highly sensitive C-reactive protein In adult Albino rats, animal groups orally received 250 mg /kg of Aloe Vera gel and 500 mg / kg of Aloe Vera gel . High-sensitive C-reactive protein was increased in the group of rats treated with Methotrexate 1 mg /kg, and sensitive C-reactive protein was lower compared with the MTX, groups received MTX 1 mg/ kg together with 250 mg /kg and in groups that received MTX 1 mg /kg together with 500 mg /kg. Conclusion: Based on the study's findings, we deduce that aloe vera gel extract, at varying dosages, can eliminate and lessen adverse effects in rats receiving methotrexate when looking at C_ Reactive Protein.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 sraa Mohammed Kadhim Al-Huchimi, Ameer Mohammed Ridha, Hassan Falih Hassan Salman Al-Ardawi

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















